HCA
$449.96-3.29%
as of close, Oct 27, 2026
☾ AH $449.96 -3.29%
HCA — HCA Healthcare Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDE
100.0150.0200.0250.0300.0350.0400.0450.0500.0020.0M40.0M$449.96—20162019202120242026
2026-10-27
Price$449.96
MA20$414.79
MA50$447.85
Vol6.7M
Key stats#
Price data
- Price
- $449.96
- YTD price return
- -3.62%
- YTD total return
- -3.10%
- Market cap
- 97.4B
- Enterprise value
- 152.5B
- Shares outstanding
- 216.5M
- 52W low
- $353.99
- 52W high
- $556.52
- From 52W high
- -19.15%
- From 52W low
- +27.11%
- 52W range
- 47%
- Beta
- 1.10
Volume
- Rel volume
- 2.14×
- 30D volume
- 1.4M
- 30D $ vol
- 601.2M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- −$29.3M
Form 4 transactions by trade date, as filed; latest on file 2026-02-18.
Fundamentals
- Sales (ttm)
- 78B
- Sales/share
- $360.33
- EPS (ttm)
- $29.86
- FCF (ttm)
- 6B
- FCF/share
- $27.70
- Book value/share
- -$30.68
- Net margin
- 8.77%
- ROA
- 10.81%
- Current ratio
- 0.99
Growth (CAGR, ttm) · 10Y
- Sales
- +7.32%+8.00%+6.85%+6.88%
- Net income
- +14.56%+5.83%+6.61%+11.12%
- FCF
- -17.77%+6.73%+56.45%+7.67%
- Shares
- -7.48%-7.32%-7.53%-5.44%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +25.86%+13.64%+15.45%+17.83%
- Sales/share
- +15.99%+16.54%+15.55%+13.09%
- FCF/share
- -11.12%+15.16%+69.18%+13.86%
- Dividend/share
- +8.70%+8.94%+24.20%n/a
- Price
- -3.83%+25.93%+12.90%+19.01%
- Total return
- -3.17%+26.89%+13.85%+19.95%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 15.1×
- Fwd P/E
- 14.7×
- P/S (ttm)
- 1.2×
- P/B (mrq)
- -14.7×
- P/FCF (ttm)
- 16.2×
- EV/EBITDA (fy)
- 10.3×
- EV/Sales (ttm)
- 2.0×
- FCF yield (ttm)
- 6.16%
- Dividend yield (fwd)
- 0.69%
- Dividend yield (ttm)
- 0.68%
- Dividend/share (fwd)
- $3.12
- Buyback yield (realized, 1y)
- 7.48%
- Shareholder yield (realized, 1y)
- 8.24%
- Buyback yield (cash, ttm)
- 8.92%
- Shareholder yield (cash, ttm)
- 9.62%
Vs own 10Y history
- P/E
- 66th
- P/S
- 71st
- P/FCF
- 78th
Bar = where today’s multiple sits in HCA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-3.29%
5D
-3.39%
1M
+3.29%
3M
+15.49%
YTD
-3.62%
1Y
-3.83%
5Y
+83.38%
Recent filings#
- Oct 27Earnings · Earnings release — EPS $6.96 vs $6.74 est. 3.3%
- Jul 24Earnings · Earnings release — EPS $7.59 vs $7.57 est. (+0.3%); revenue $20.23B (+9% y/y) 1.5%
- Jul 148-K · Results of operations; Regulation FD disclosure
Financial statements
Open full HCA financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
